5-((3AS,4S,6aR)-3-benzyl-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoic acid

Catalog No. :
ACFIVQ264
CAS No. :
57229-92-2
Molecular Formula :
C17H22N2O3S
Molecular Weight :
334.44

IUPAC Name:5-((3aS,4S,6aR)-3-benzyl-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoic acid

5-((3AS,4S,6aR)-3-benzyl-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-((3AS,4S,6aR)-3-benzyl-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoic acid
IUPAC Name5-((3aS,4S,6aR)-3-benzyl-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoic acid
Molecular FormulaC17H22N2O3S
Molecular Weight334.44
SMILESO=C(O)CCCC[C@@H]1SC[C@]([C@]1([H])N2CC3=CC=CC=C3)([H])NC2=O
InChI KeyQHDPYNGBWBKNRO-DZKIICNBSA-N
Synonym(3aS,4S,6aR)-Hexahydro-2-oxo-3-(phenylMethyl)-H-thieno[3,4-d]iMidazole -4-pentanoic Acid;[3aS-(3aα,4β,6aα)]-;Biotin IMpurity E;3'N-Benzyl Biotin;Biotin N3-Benzyl Impurity;1H-Thieno[3,4-d]imidazole-4-pentanoic acid, hexahydro-2-oxo-3-(phenylmethyl)-, (3aS,4S,6aR)-;5-((3aS,4S,6aR)-3-benzyl-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoic acid/5-((3aS,4S,6aR)-1-benzyl-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoic acid;(3aS,4S,6aR)-Hexahydro-2-oxo-3-(phenylmethyl)-1H-thieno[3,4-d]imidazole-4-pentanoic acid
CAS No.57229-92-2

Synthetic Route by SureRoute

1. ACFIVQ264 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFIVQ264 route product structure diagram
    ACFIVQ26457229-92-2
Inquiry

2. ACFIVQ264 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFIVQ264 route product structure diagram
    ACFIVQ26457229-92-2
Inquiry

Comments (0)